Ying Cheng

机构：Wenzhou Medical University, Dongyang People's Hospital · ORCID：0009-0008-8384-2647

发表论文 78 篇 · 总被引 1104 次 · h-index 13

代表论文

• Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (2024 · New England Journal of Medicine · 被引 307)
• Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer (2024 · Cancer Cell · 被引 22)
• Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study (2024 · The Lancet Respiratory Medicine · 被引 9)
• First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up of Chinese pts from CheckMate 649. (2025 · Journal of Clinical Oncology · 被引 7)
• Quercetin can improve anesthesia induced neuroinflammation and cognitive dysfunction by regulating miR-138-5p/ LCN2 (2025 · BMC Anesthesiology · 被引 7)
• Abstract CT008: First-in-human study of SYS6010, a novel EGFR targeting antibody drug conjugate (ADC) for patients with advanced solid tumors (2025 · Cancer Research · 被引 5)